Brief: Vaccinex Inc - Filed A Prospectus Supplement Under Which, Co May Offer And Sell, Shares Of Its Common Stock Of Up To $4.4 Million
19/05/2023 22:23
Vaccinex Inc VCNX.O :
* VACCINEX INC - FILED A PROSPECTUS SUPPLEMENT UNDER WHICH,
CO MAY
OFFER AND SELL, SHARES OF ITS COMMON STOCK OF UP TO $4.4 MILLION
Source text for Eikon: ID:
Further company coverage: VCNX.O
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease